{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:39:46Z","timestamp":1790779186934,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.path.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T18:07:24Z","timestamp":1525802844000},"page":"329-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Primary Biliary Cholangitis and Autoimmune Hepatitis"],"prefix":"10.1016","volume":"11","author":[{"given":"Raul S.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/hupa.2002.128060","article-title":"Destruction of canals of Hering in primary biliary cirrhosis","volume":"33","author":"Saxena","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0034-1383730","article-title":"The new epidemiology of primary biliary cirrhosis","volume":"34","author":"Griffiths","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.path.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.path.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A\u00a0genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1386-6346(99)00005-4","article-title":"Elevation of serum gamma-glutamyl transpeptidase precedes that of alkaline phosphatase in the early stages of primary biliary cirrhosis","volume":"3","author":"Matsuo","year":"1999","journal-title":"Hepatol Res"},{"key":"10.1016\/j.path.2018.02.010_bib11","first-page":"47","article-title":"Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies","volume":"10","author":"Gershwin","year":"1992","journal-title":"Prog Liver Dis"},{"key":"10.1016\/j.path.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clinre.2016.06.001","article-title":"The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis","volume":"40","author":"Ozaslan","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.21.10.878","article-title":"Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance","volume":"21","author":"Kurki","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.path.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.path.2018.02.010_bib16","first-page":"365","article-title":"Autoimmune associations in primary biliary cirrhosis","volume":"57","author":"Culp","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.path.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.path.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.3800684","article-title":"Autoimmune liver disease: overlap and outliers","volume":"20","author":"Washington","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.path.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/PAS.0b013e31824b1dff","article-title":"Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis","volume":"36","author":"Graham","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2559.2009.03391.x","article-title":"Cytokeratin expression as an aid to diagnosis in medical liver biopsies","volume":"56","author":"Bateman","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2018.02.010_bib23","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.path.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.path.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bpg.2010.07.006","article-title":"Primary biliary cirrhosis","volume":"24","author":"Nguyen","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.010_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3748\/wjg.v16.i4.453","article-title":"Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease","volume":"16","author":"Moreira","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib30","series-title":"Practical hepatic pathology: a diagnostic approach","first-page":"327","article-title":"Liver injury due to drugs and herbal agents","author":"Kleiner","year":"2018"},{"key":"10.1016\/j.path.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF01728613","article-title":"Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9","volume":"64","author":"Berg","year":"1986","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.path.2018.02.010_bib32","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s10620-014-3216-1","article-title":"Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis","volume":"59","author":"Paul","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.path.2018.02.010_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.dld.2017.05.001","article-title":"Primary biliary cholangitis: advances in management and treatment of the disease","volume":"49","author":"Invernizzi","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.path.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","article-title":"Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation","volume":"31","author":"Visseren","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.path.2018.02.010_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.path.2018.02.010_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.path.2018.02.010_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00535-012-0586-z","article-title":"Autoimmune hepatitis: a review","volume":"47","author":"Gossard","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib41","first-page":"1","article-title":"Epidemiology and treatment of autoimmune hepatitis","volume":"4","author":"Francque","year":"2012","journal-title":"Hepat Med"},{"key":"10.1016\/j.path.2018.02.010_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.010_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-010-9183-5","article-title":"Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management","volume":"4","author":"Oo","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.path.2018.02.010_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the histopathological key features in autoimmune hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2018.02.010_bib47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/PAS.0000000000000395","article-title":"Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis","volume":"39","author":"Tucker","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.dld.2017.04.001","article-title":"Glassy droplet inclusions within the cytoplasm of Kupffer cells: a novel ultrastructural feature for the diagnosis of pediatric autoimmune hepatitis","volume":"49","author":"Lotowska","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.path.2018.02.010_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","article-title":"Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients","volume":"70","author":"Nguyen Canh","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib50","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.path.2018.02.010_bib51","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2018.02.010_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib53","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.humpath.2003.10.017","article-title":"Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis","volume":"35","author":"Brunt","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib55","series-title":"Atlas of liver pathology","first-page":"136","author":"Chan","year":"2014"},{"key":"10.1016\/j.path.2018.02.010_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/73.1.12","article-title":"Histology of the liver in Wilson's disease: a study of 34 cases","volume":"73","author":"Stromeyer","year":"1980","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/modpathol.2009.94","article-title":"IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material","volume":"22","author":"Deshpande","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2018.02.010_bib58","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2018.02.010_bib59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOT.0b013e3283536622","article-title":"Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation","volume":"17","author":"Fiel","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.path.2018.02.010_bib60","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","article-title":"Difficult treatment decisions in autoimmune hepatitis","volume":"16","author":"Czaja","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S101440","article-title":"Autoimmune hepatitis: current challenges and future prospects","volume":"10","author":"Aizawa","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.path.2018.02.010_bib62","doi-asserted-by":"crossref","first-page":"e13001","DOI":"10.1111\/ctr.13001","article-title":"Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list","volume":"31","author":"Ruiz","year":"2017","journal-title":"Clin Transplant"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T18:24:04Z","timestamp":1534875844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918118300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1875918118300102"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2018.02.010","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Biliary Cholangitis and Autoimmune Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}